Adenosine monophosphate is elevated in the bronchoalveolar lavage fluid of mice with acute respiratory toxicity induced by nanoparticles with high surface hydrophobicity

References

• Aitken R, Borm P, Donaldson K, Ichihara G, Loft S, Marano F, et al. 2009. Nanoparticles – one word: a multiplicity of different hazards. Nanotoxicol 3:263–4
   Web of Science ®Google Scholar
• Barletta KE, Ley K, Mehrad B. 2012. Regulation of neutrophil function by adenosine. Arterioscler Thromb Vasc Biol 32:856–64
   PubMed Web of Science ®Google Scholar
• Beyerle A, Braun A, Banjeree A, Ercal N, Eickelberg O, Kissel T, Stoeger T. 2011. Inflammatory responses to pulmonary application of PEI-based siRNA nanocarriers in mice. Biomaterials 32:8694–701
   PubMed Web of Science ®Google Scholar
• Bivas-Benita M, Zwier R, Junginger HE, Borchard G. 2005. Non-invasive pulmonary aerosol delivery in mice by the endotracheal route. Eur J Pharm Biopharm 61:214–18
   PubMed Web of Science ®Google Scholar
• Blackburn MR, Vance CO, Morschl E, Wilson CN. 2009. Adenosine receptors and inflammation. In Wilson CN & Mustafa SJ, eds. Adenosine Receptors in Health and Disease. Heidelberg: Springer-Verlag, 215–69
   Google Scholar
• Brown DM, Wilson MR, MacNee W, Stone V, Donaldson K. 2001. Size-dependent proinflammatory effects of ultrafine polystyrene particles: a role for surface area and oxidative stress in the enhanced activity of ultrafines. Toxicol Appl Pharmacol 175:191–9
   PubMed Web of Science ®Google Scholar
• Bu Q, Yan G, Deng P, Peng F, Lin H, Xu Y, et al. 2010. NMR-based metabonomic study of the sub-acute toxicity of titanium dioxide nanoparticles in rats after oral administration. Nanotechnology 21:125105
   PubMed Web of Science ®Google Scholar
• Burch LH, Picher M. 2006. E-NTPDases in human airways: regulation and relevance for chronic lung diseases. Purinergic Signal 2:399–408
   PubMedGoogle Scholar
• Button BM, Button B. 2013. Structure and function of the mucus clearance system of the lung. Cold Spring Harb Perspect Med 3:a009720
   Google Scholar
• Carstensen H, Müller BW, Müller RH. 1991. Adsorption of ethoxylated surfactants on nanoparticles: 1. Characterization by hydrophobic interaction chromatography. Int J Pharm 67:29–37
   Web of Science ®Google Scholar
• Chana J, Forbes B, Jones SA. 2008. The synthesis of high molecular weight partially hydrolysed poly(vinyl alcohol) grades suitable for nanoparticle fabrication. J Nanosci Nanotech 8:5739–47
   PubMed Web of Science ®Google Scholar
• Cho WS, Duffin R, Thielbeer F, Bradley M, Megson IL, MacNee W, et al. 2012. Zeta potential and solubility to toxic ions as mechanisms of lung inflammation caused by metal/metal oxide nanoparticles. Toxicol Sci 126:469–77
   PubMed Web of Science ®Google Scholar
• Dailey LA. 2009. Considerations for the design of toxicity studies of inhaled nanomedicines. In: Sahu SC & Casciano DA, eds. Nanotoxicity. From In Vivo and In Vitro Models to Health Risks. Chichester: John Wiley & Sons Ltd, 41–60
   Google Scholar
• Dailey LA, Jekel N, Fink L, Gessler T, Schmehl T, Wittmar M, et al. 2006. Investigation of the proinflammatory potential of biodegradable nanoparticle drug delivery systems in the lung. Toxicol Appl Pharmacol 215:100–8
   PubMed Web of Science ®Google Scholar
• Donaldson K, Borm PJA, Oberdörster G, Pinkerton KE, Stone V, Tran CL. 2008. Concordance between in vitro and in vivo dosimetry in the proinflammatory effects of low-toxicity, low-solubility particles: the key role of the proximal alveolar region. Inhal Toxicol 20:53–62
   PubMed Web of Science ®Google Scholar
• Donaldson K, Stone V, Gilmour PS, Brown DM, MacNee W. 2000. Ultrafine particles: mechanisms of lung injury. Philosoph Trans Royal Soc London Ser a-Math Phys Eng Sci 358:2741–8
   Web of Science ®Google Scholar
• Duffin R, Tran L, Brown D, Stone V, Donaldson K. 2007. Proinflammogenic effects of low-toxicity and metal nanoparticles in vivo and in vitro: highlighting the role of particle surface area and surface reactivity. Inhal Toxicol 19:849–56
   PubMed Web of Science ®Google Scholar
• Esther CR, Alexis NE, Clas ML, Lazarowski ER, Donaldson SH, Rlbeiro CMP, et al. 2008a. Extracellular purines are biomarkers of neutrophilic airway inflammation. Eur Resp J 31:949–56
   PubMed Web of Science ®Google Scholar
• Esther CR, Boysen G, Olsen BM, Collins LB, Ghio AJ, Swenberg JW, Boucher RC. 2009. Mass spectrometric analysis of biomarkers and dilution markers in exhaled breath condensate reveals elevated purines in asthma and cystic fibrosis. Am J Physiol Lung Cell Mol Physiol 296:L987–93
   Web of Science ®Google Scholar
• Esther CR, Jasin HM, Collins LB, Swenberg JA, Boysen G. 2008b. A mass spectrometric method to simultaneously measure a biomarker and dilution marker in exhaled breath condensate. Rapid Commun Mass Spectrom 22:701–5
   PubMed Web of Science ®Google Scholar
• Fadeel B, Pietrouitisi A, Shvendova AA. 2012. Adverse effects of engineered nanomaterials: exposure, toxicology, and impact on human health. London. Waltham, MA: Elsevier/Academic Press
   Google Scholar
• Garcia-Perez I, Earll ME, Angulo S, Barbas C, Legido-Quigely C. 2010. Chemometric analysis of urine fingerprints acquired by liquid chromatography-mass spectrometry and capillary electrophoresis: Application to the schistosomiasis mouse model. Electrophoresis 31:2349–55
   PubMed Web of Science ®Google Scholar
• Harush-Frenkel O, Bivas-Benita M, Nassar T, Springer C, Sherman Y, Avital A, et al. 2010. A safety and tolerability study of differently-charged nanoparticles for local pulmonary drug delivery. Toxicol Appl Pharmacol 246:83–90
   PubMed Web of Science ®Google Scholar
• Heurtault B, Saulnier P, Pech B, Benoit JP, Proust JE. 2003. Interfacial stability of lipid nanocapsules. Coll Surf B-Biointerfaces 30:225–35
   Web of Science ®Google Scholar
• Hu JZ, Rommereim DNR, Minard KR, Woodstock A, Harrer BJ, Wind RA, et al. 2008. Metabolomics in lung inflammation: a high-resolution 1H NMR study of mice exposed to silica dust. Toxicol Mech Methods 18:385–98
   PubMed Web of Science ®Google Scholar
• Jackson EK, Ren J, Mi Z. 2009. Extracellular 2′,3′-cAMP is a source of adenosine. J Biol Chem 284:33097–106
   Google Scholar
• Jacob F, Novo CP, Bachert C, Van Crombruggen K. 2013. Purinergic signaling in inflammatory cells: P2 receptor expression, functional effects, and modulation of inflammatory responses. Purinergic Signal 9:285–306
   Google Scholar
• Lei RH, Wu CQ, Yang BH, Ma HZ, Shi C, Wang QJ, et al. 2008. Integrated metabolomic analysis of the nano-sized copper particle-induced hepatotoxicity and nephrotoxicity in rats: a rapid in vivo screening method for nanotoxicity. Toxicol Appl Pharmacol 232:292–301
   PubMed Web of Science ®Google Scholar
• Liu YJ, Ibricevic A, Cohen JA, Cohen JL, Gunsten SP, Frechet JMJ, et al. 2009. Impact of hydrogel nanoparticle size and functionalization on in vivo behavior for lung imaging and therapeutics. Mol Pharm 6:1891–902
   PubMedGoogle Scholar
• Lorusso D, Di Stefano A, Carone V, Fagotti A, Pisconti S, Scambia G. 2007. Pegylated liposomal doxorubicin-related palmar-plantar erythrodysesthesia (‘hand-foot’ syndrome). Ann Oncol 18:1159–64
   PubMed Web of Science ®Google Scholar
• Lu XY, Tian Y, Zhao QQ, Jin TT, Xiao S, Fan XH. 2011. Integrated metabonomics analysis of the size-response relationship of silica nanoparticles-induced toxicity in mice. Nanotechnology 22:055101 (1–16)
   Web of Science ®Google Scholar
• Maynard AD, Warheit DB, Philbert MA. 2011. The new toxicology of sophisticated materials: nanotoxicology and beyond. Toxicol Sci 120:S109–29
   Web of Science ®Google Scholar
• Moghimi SM, Szebeni J. 2003. Stealth liposomes and long circulating nanoparticles: critical issues in pharmacokinetics, opsonization and protein-binding properties. Prog Lipid Res 42:463–78
   PubMed Web of Science ®Google Scholar
• Nalwa HS. 2009. Soft Nanomaterials. Stevenson Ranch, CA: American Scientific Publishers
   Google Scholar
• Nassimi M, Schleh C, Lauenstein HD, Hussein R, Lübbers K, Pohlmann G, et al. 2009. Low cytotoxicity of solid lipid nanoparticles in in vitro and ex vivo lung models. Inhal Toxicol 21:104–9
   PubMedGoogle Scholar
• Patel K, Davis SD, Johnson R, Esther CR. 2013. Exhaled breath condensate purines correlate with lung function in infants and preschoolers. Ped Pulmonol 48:182–7
   PubMed Web of Science ®Google Scholar
• Picher M, Burch LH, Boucher RC. 2004. Metabolism of P2 receptor agonists in human airways – implications for mucociliary clearance and cystic fibrosis. J Biol Chem 279:20234–41
   PubMed Web of Science ®Google Scholar
• Picher M, Burch LH, Hirsh AJ, Spychala J, Boucher RC. 2003. Ecto 5′-nucleotidase and nonspecific alkaline phosphatase – two amp-hydrolyzing ectoenzymes with distinct roles in human airways. J Biol Chem 278:13468–79
   PubMed Web of Science ®Google Scholar
• Reutershan J, Vollmer I, Stark S, Wagner R, Ngamsri KC, Eltzschig HK. 2009. Adenosine and inflammation: CD39 and CD73 are critical mediators of LPS-induced PMN trafficking into the lungs. FASEB J 23:473–82
   PubMed Web of Science ®Google Scholar
• Robson SC, Sevigny J, Zimmermann H. 2006. The E-NTPDase family of ectonucleotidases: structure function relationships and pathophysiological significance. Purinergic Signal 2:409–30
   PubMedGoogle Scholar
• Ruge CA, Schaefer UF, Herrmann J, Kirch J, Canadas O, Echaide M, et al. 2012. The interplay of lung surfactant proteins and lipids assimilates the macrophage clearance of nanoparticles. PLoS One 7:e40775
   PubMed Web of Science ®Google Scholar
• Schmidt EP, Tuder RM. 2010. Role of apoptosis in amplifying inflammatory responses in lung disease. J Cell Death 3:41–53
   PubMedGoogle Scholar
• Singh R, Lillard JW. 2009. Nanoparticle-based targeted drug delivery. Exp Mol Pathol 86:215–23
   PubMed Web of Science ®Google Scholar
• Vaine CA, Patel MK, Zhu JT, Lee E, Finberg RW, Hayward RC, Kurt-Jones EA. 2013. Tuning innate immune activation by surface texturing of polymer microparticles: the role of shape in inflammasome activation. J Immunol 190:3525–32
   PubMed Web of Science ®Google Scholar
• Whiley L, Godzien J, Ruperez FJ, Legido-Quigley C, Barbas C. 2012. In-vial dual extraction for direct LC-MS analysis of plasma for comprehensive and highly reproducible metabolic fingerprinting. Anal Chem 84:5992–9
   PubMed Web of Science ®Google Scholar
• Wolak JE, Esther CR, O’Connell TM. 2009. Metabolomic analysis of bronchoalveolar lavage fluid from cystic fibrosis patients. Biomarkers 14:55–60
   PubMed Web of Science ®Google Scholar
• Xiayan L, Legido-Quigley C. 2008. Advances in separation science applied to metabonomics. Electrophoresis 29:3724–36
   PubMed Web of Science ®Google Scholar